| 000 | 01830 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516131449.0 | ||
| 264 | 0 | _c20130906 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1520-5126 | ||
| 024 | 7 |
_a10.1021/ja308784w _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMagnan, Rémi | |
| 245 | 0 | 0 |
_aDistinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist. _h[electronic resource] |
| 260 |
_bJournal of the American Chemical Society _cFeb 2013 |
||
| 300 |
_a2560-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdamantane _xanalogs & derivatives |
| 650 | 0 | 4 |
_aArrestins _xchemistry |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicroscopy, Confocal |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xpharmacology |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aReceptor, Cholecystokinin B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aType C Phospholipases _xchemistry |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _abeta-Arrestin 2 |
| 650 | 0 | 4 | _abeta-Arrestins |
| 700 | 1 | _aEscrieut, Chantal | |
| 700 | 1 | _aGigoux, Véronique | |
| 700 | 1 | _aDe, Kavita | |
| 700 | 1 | _aClerc, Pascal | |
| 700 | 1 | _aNiu, Fan | |
| 700 | 1 | _aAzema, Joelle | |
| 700 | 1 | _aMasri, Bernard | |
| 700 | 1 | _aCordomi, Arnau | |
| 700 | 1 | _aBaltas, Michel | |
| 700 | 1 | _aTikhonova, Irina G | |
| 700 | 1 | _aFourmy, Daniel | |
| 773 | 0 |
_tJournal of the American Chemical Society _gvol. 135 _gno. 7 _gp. 2560-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/ja308784w _zAvailable from publisher's website |
| 999 |
_c22423044 _d22423044 |
||